- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06815315
Evaluating of the Impact of Micronutrient Interventions Among Adolescents in Mozambique
February 3, 2025 updated by: World Vision US
A Formative, Mixed-Methods Evaluation Assessing the Acceptability, Feasibility, and Effectiveness of Micronutrient Interventions Among Adolescents in Mozambique
This purpose of this study is to assess effects of iron and folic acid supplementation and multiple micronutrient supplementation on anemia status and the impact of a nutrition curriculum on diet diversity and anemia knowledge among adolescent girls.
Study Overview
Status
Completed
Conditions
Detailed Description
This study aimed to implement and evaluate micronutrient supplementation interventions to improve adolescent nutrition, health, and education in Mozambique.
In conjunction with the Mozambique Ministries of Health, Education and Culture, we conducted a two-arm cluster-randomized trial in three secondary schools, enrolling 28 girls' clubs (14 per arm).
Each club was comprised of around 18 girls aged 13 to 20 years.
Using constrained sampling to balance for age and school, clubs were randomly assigned to one of two intervention groups: 1) Multiple Micronutrient Supplementation (MMS) for five months plus a Nutrition Curriculum, or 2) Iron and Folic Acid Supplementation (IFAS) plus a Nutrition Curriculum.
Girls enrolled in the MMS arm consumed supplements daily for 4 months at home and weekly nutrition messages delivered through the clubs.
Girls enrolled in the IFAS arm consumed supplements once a week for 4 months at school (the standard of care) and weekly nutrition messages delivered through the clubs.
The study evaluated the effects of MMS and IFAS on anemia status and the impact of the nutrition curriculum on diet diversity and anemia knowledge.
Study Type
Interventional
Enrollment (Actual)
490
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nampula Province
-
Monapo, Nampula Province, Mozambique
- World Vision Monapo Field Office
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Adolescents aged 13-20 years Enrolled in secondary school at study initiation Member of an IMPACT+ Girls Club at one of the participating schools Consent provided by the parent Assent provided by the adolescent
Exclusion Criteria:
No informed consent from parent or assent from adolescent Self-reported pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Multiple Micronutrient Supplementation (MMS) Arm
The adolescent girls randomly assigned to the MMS arm consumed MMS for four months and participated in girls' clubs where they received nutrition messages.
|
The multiple micronutrient supplementation composition follows the United Nations International Multiple Micronutrient Antenatal Preparation.
Each MMS tablet contains 15 micronutrients, including iron (30mg), folic acid (400 mcg), Vit A, Retinol (800 RE), vit D (200 IU), vit E (10 mg), vit C (70 mg), vit B1 (1.4 mg), vit B2 (1.4 mg), vit B6 (1.9 mg), vit B12 (2.6 mcg), niacin (18 mg), zinc (15 mg), copper (2 mg), iodine (150 mcg), selenium (65 mcg) and is consumed daily.
The Adolescent Nutrition Curriculum includes five modules focused on promoting healthy behaviors to enhance nutrition, with an emphasis on consuming iron-rich foods.
|
|
Active Comparator: Iron Folic Acid Supplementation (IFAS) Arm
The adolescent girls randomly assigned to the IFAS arm consumed IFAS for four months and participated in girls' clubs where they received nutrition messages
|
The Adolescent Nutrition Curriculum includes five modules focused on promoting healthy behaviors to enhance nutrition, with an emphasis on consuming iron-rich foods.
One IFAS tablet contains Iron (60 mg) and Folic Acid (2800 μg) and is taken weekly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anemia Status
Time Frame: 6 months
|
Anemia is defined as hemoglobin level <10 g/dL
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anemia Knowledge
Time Frame: 6 months
|
Changes in knowledge from baseline to endline around anemia causes and strategies to prevent anemia.
|
6 months
|
|
Minimum Dietary Diversity Score
Time Frame: 6 months
|
The minimum dietary diversity score measures girls and women who 10 possible food groups over a 24-hour recall period are classified as having minimally adequate diet diversity.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sarah A Bauler, DrPH(c), World Vision International
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Actual)
September 30, 2024
Study Completion (Actual)
December 31, 2024
Study Registration Dates
First Submitted
February 3, 2025
First Submitted That Met QC Criteria
February 3, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 3, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WorldVision
- 218961 (Other Grant/Funding Number: World Vision Canada)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
With permission from the Mozambique Ministry of Health Commitee for Bioethics, the quantitative dataset supporting the conclusions of this study can be found in the Humanitarian Data Exchange at https://data.humdata.org.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Italy, Spain, United Kingdom, Hungary
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Netherlands, Germany, Italy, United Kingdom, United States, France
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
China Immunotech (Beijing) Biotechnology Co., Ltd.Not yet recruitingAutoimmune Hemolytic AnemiaChina
-
Peking Union Medical College HospitalNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingSevere Aplastic Anemia | Refractory Aplastic Anemia | Newly Diagnosed Aplastic Anemia
-
Chinese PLA General HospitalBeijing Friendship Hospital; Beijing 302 Hospital; The University of Hong Kong-Shenzhen... and other collaboratorsEnrolling by invitationSevere Aplastic Anemia | Severe Aplastic Anemia (SAA) | Severe Aplastic Anemia, RefractoryChina
-
Chen MiaoNot yet recruiting
-
Incyte CorporationTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom, Belgium
Clinical Trials on Multiple micronutrient supplementation
-
National Institute of Neurosciences and Hospital...Directorate General of Health Services, BangladeshActive, not recruitingPregnant Women | Pregnant Women and Their OffspringBangladesh
-
International Centre for Diarrhoeal Disease Research...Children's Investment Fund FoundationRecruitingInfant, Low Birth WeightBangladesh
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; Aga Khan University; Children's Investment... and other collaboratorsRecruitingAnemia, Iron DeficiencyPakistan, Burkina Faso
-
University of British ColumbiaRecruitingAnemia | Pregnancy | Adherence | Micronutrients | Supplement | Health Systems | Supply Chain VulnerabilitiesCambodia
-
George Washington UniversityColumbia University; Harvard School of Public Health (HSPH); Ifakara Health Institute and other collaboratorsRecruitingPregnancy RelatedTanzania
-
George Washington UniversityColumbia University; Harvard School of Public Health (HSPH); Ifakara Health Institute and other collaboratorsActive, not recruitingPregnancy RelatedTanzania
-
Johns Hopkins Bloomberg School of Public HealthUNICEF; Vitamin Angels; Child and Family Foundation of Uganda; Kirk HumanitarianRecruitingNutrient DeficiencyUganda
-
Aga Khan UniversityThe Hospital for Sick Children; European UnionCompleted
-
GlaxoSmithKlineMahajan Imaging CenterCompleted
-
Helen Keller InternationalJohns Hopkins University; Eleanor Crook FoundationActive, not recruiting